U.S. Markets closed

Pfizer: Why This Blue-Chip Dividend Stock Is a Buy Today

Nick McCullum

The company was founded in 1849, trades with a market capitalization of $217 billion and a dividend yield of 3.7%, and has paid eight years of rising dividends to shareholders. In this article, we'll investigate Pfizer's business model, financial performance, and growth prospects to determine whether the company is worth investing in today. Pfizer is one of the world's largest and most distinguished pharmaceutical companies.